Therefore, the strategic manipulation of CD8+ T cells represent a fundamental therapeutic approach that spans infectious disease control, cancer treatment, and autoimmunity, underscoring their indispensable role in advancing immunotherapy and vaccine development [7–9]. This evidence concerns the gene CD8A and cancer.